Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|September 11, 2012
Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorderOscar Gary Bukstein, Jared Head
Biorxiv : the Preprint Server for Biology|December 15, 2025
Engineering a Bright Near-Infrared Fluorescent Protein by Screening a Comprehensive Phenotypic LandscapeDevon L Kulhanek, Qiyao Wei, Jared Head, et al.
Protein Science : a Publication of the Protein Society|May 6, 2026
Engineering a bright near-infrared fluorescent protein by screening a comprehensive phenotypic landscapeDevon L Kulhanek, Qiyao Wei, Jared Head, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2019
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease ModelsPhilipp Haselmayer, Montserrat Camps, Lesley Liu-Bujalski, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2018
Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of BtkRichard Caldwell, Lesley Liu-Bujalski, Hui Qiu, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2018
Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hitHui Qiu, Lesley Liu-Bujalski, Richard D Caldwell, et al.
Chemmedchem|December 7, 2018
Discovery of Affinity-Based Probes for Btk Occupancy AssaysHui Qiu, Richard Caldwell, Lesley Liu-Bujalski, et al.
Clinical Immunology (Orlando, Fla.)|January 29, 2016
Btk inhibition treats TLR7/IFN driven murine lupusAndrew T Bender, Albertina Pereira, Kai Fu, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2018
Optimization of the efflux ratio and permeability of covalent irreversible BTK inhibitorsHui Qiu, Lesley Liu-Bujalski, Richard D Caldwell, et al.
Pageof 2